Ticagrelor better than clopidogrel in early invasive treatment of ACS
20 January 2010
| by Nicola Garrett
A sub-analysis of the PLATO study shows the platelet inhibitor ticagrelor is superior to clopidogrel among acute coronary syndromes (ACS) patients due to undergo invasive management....
Want to read complete article? Please Sign in or Register.